Skip to main content

Table 4 HPLC Analysis of Artemisinin derivative (AD) of ACT

From: Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use

Artemisinin Derivative Below 85 % Within 85–115 % Above 115 % Total
n (%) n (%) n (%) N = 254
Artesunatea
n (%)
25 (22.5) 86 (77.5) 0 (0.0) 111 (100.0)
Median (IQR) 80.0 (77.2–82.7) 92.9 (89.5–98.6) 0 91.5 (86.0–95.8)
Artemetherb
n (%)
6 (4.5) 126 (94.0) 2 (1.5) 134 (100.0)
Median (IQR) 76.6 (66.8–77.5) 95.9 (92.1–100.4) 116.1 (115.1–117.0) 95.6 (91.5–100.5)
Dihydroartemisinc
n (%)
0 (0.0) 6 (66.7) 3 (33.3) 9 (100.0)
Median (IQR) 0 105.1 (89.2–107.3) 132.4 (120.3–143.2) 107.3 (103.4–120.3)
Combined
n (%)
31 (12.2) 218 (85.0) 5 (2.0) 254 (100.0)
Median (IQR) 78.7 (76.7–82.5) 94.6 (90.9–99.9) 120.3 (117.0–132.4) 93.6 (89.4–99.7)
  1. Note: a, b, cwere derived from Artesunate Amodiaquine. Artemether Lumefantrine and Dihydroartemisinin Piperaquine respectively